Addressing the implications of GLP-1 medications through informed consent and thorough patient education ensures that patients understand the potential risks and are better prepared to manage their health effectively
Their results also suggested that NK1 and NK3 receptors may induce glandular effects by different mechanisms NK3 receptors are likely inducing activation of parasympathetic nerves, while NK1 may have direct effect on the glands [80]
The brand calls it a first-of-its-kind program that integrates GLP-1 medications as part of a larger preventive health program. Its website notes that patients receive personalized microdoses of GLP-1 medication, regular at-home biomarker testing and Nooms digital healthy habits platform to empower people with data, insights, personalized action plans and the motivational support to take control of their long-term wellbeing. Ahead, we break down why microdosing is resonating right now, what problem Noom says its addressing and who may be eligible
Because it is a small-molecule, non-peptide GLP-1 receptor agonist, it can be absorbed without the specialized delivery technology required for semaglutide tablets
2018;8(1) doi: 10.1038/s41598-018-36210-9
